Ian marschner pfizer australia nhmrc clinical trials centre
This presentation is the property of its rightful owner.
Sponsored Links
1 / 32

Ian Marschner Pfizer Australia & NHMRC Clinical Trials Centre PowerPoint PPT Presentation


  • 75 Views
  • Uploaded on
  • Presentation posted in: General

Biases in identifying risk factor thresholds: A new look at the "lower-is-better" controversy for cholesterol, blood pressure and other risk factors. Ian Marschner Pfizer Australia & NHMRC Clinical Trials Centre. Linear Relationship.

Download Presentation

Ian Marschner Pfizer Australia & NHMRC Clinical Trials Centre

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Ian marschner pfizer australia nhmrc clinical trials centre

Biases in identifying risk factor thresholds: A new look at the "lower-is-better" controversy for cholesterol, blood pressure and other risk factors

Ian Marschner

Pfizer Australia & NHMRC Clinical Trials Centre


Linear relationship

Linear Relationship

  • Relationship between a risk factor and the occurrence of a disease event is essentially linear on an appropriate scale (usually the log-incidence scale)

  • Existence of a linear relationship suggests a “lower-is-better” approach to risk factor modification


Example coronary and vascular events related to cholesterol and blood pressure

Example – Coronary and Vascular events related to cholesterol and blood pressure

Mortality per 1000 per year

Relative Risk

Law & Wald. BMJ 2002.


Threshold relationship

Threshold Relationship

  • Threshold:pointatwhichapredominantlylinearrelationshipbetweenariskfactorandadiseaseeventbecomeseffectivelyconstant

  • Existenceofathresholdrelationshipcansuggestlessaggressiveriskfactormodificationstrategiessincemodificationisofnobenefitbeyondacertainpoint


Example care trial

Example – CARE Trial

Relative risk (log scale)

of recurrent coronary event

LDL Cholesterol level (mg/dL)


J curve relationship

J-Curve Relationship

  • J-curve:predominantlylinearpositiverelationshipbetweenariskfactorandadiseaseeventreversesandbecomesnegative

  • ExistenceofaJ-curverelationshipcansuggestlessaggressiveriskfactormodificationstrategiessincemodificationisofnobenefitandmayevenbeharmfulbeyondacertainpoint


Example framingham study

Example – Framingham Study

Note: J-curves have

also been observed

for stroke events


Randomised studies

Randomised Studies

  • Randomised studies of intensive versus moderate lowering of cholesterol support lower-is-better e.g. PROVE-IT study:


Example care trial1

Example – CARE Trial

Relative risk (log scale)

of recurrent coronary event

LDL Cholesterol level (mg/dL)


Randomised studies1

Randomised Studies

  • Randomised studies of intensive versus moderate lowering of cholesterol support lower-is-better e.g. PROVE-IT study:


Conflicting evidence

Conflicting Evidence

  • Existence of conflicting evidence has complicated the assessment of whether lower-is-better for cholesterol and blood pressure

  • One explanation for this is that bias has led to spurious non-linear threshold or J-curve relationships in some studies, particularly those on primary or secondary prevention cohorts


Explanation for conflicting evidence

Explanation for conflicting evidence

  • Confounding of primary risk factor and residual risk level in primary or secondary prevention studies

    • E.g. cholesterol level confounded with non-cholesterol risk level

  • Effect modification often exists between primary risk factor and residual risk level

    • E.g. risk coronary event increases more quickly with cholesterol when the individual has lower non-cholesterol risk level

  • Combined effect of confounding and effect modification is a spurious non-linear relationship even when the underlying relationship is a linear lower-is-better one


Plan for rest of talk

Plan for rest of talk

  • Provide evidence that there is confounding in primary and secondary prevention studies

  • Provide evidence that effect modification can exist, particularly in cardiovascular contexts

  • Explain how the two can combine to produce spurious non-linear relationships that could explain the apparent threshold and J-curve relationships seen in some prior studies


Confounding

Confounding

  • Inpatientsselectedbecausetheyhavehadapreviousevent(secondaryprevention)orbecausetheyhavenothadapreviousevent(primaryprevention)theriskfactorandtheresidualrisklevelisconfounded

  • Example1:Inordertohavehadapriorheartattack,patientswithlowcholesterolhavemorenon-cholesterolriskfactors

  • Example2:Inordernottohavehadapriorheartattack,patientwithhighcholesterolhavelessnon-cholesterolriskfactors


Example simulation results

Example – Simulation Results

Assumptions for simulated population:

Incidence of coronary event is related to 8 risk factors (incl. cholesterol) according to a model

No relationship between cholesterol and no. of non-cholesterol risk factors in the full population

Coronary events simulated according to the risk factor model

Primary and secondary prevention sub-populations identified


Example lipid trial

Example – LIPID Trial


Effect modification

Effect Modification

  • EffectModification:Eventrateincreaseslessquicklyastheriskfactorincreasesinpatientswithhigherresidualrisk

  • Examples:Coronaryandvasculareventrateincreaseslessquicklywithcholesterollevelandbloodpressureinpatientswithhighernon-cholesterolandnon-BPrisklevel


Ian marschner pfizer australia nhmrc clinical trials centre

ExamplesLIPID: Rate ratio of coronary event for each unit of cholesterolLaw: Rate ratio of coronary event for each unit of cholesterolPSC: Rate ratio of vascular event for each unit of blood pressure


Combination of confounding and effect modification

Combination of Confounding and Effect Modification

  • Confounding alone leads to linear attenuation of the risk factor relationship

    • Strength of association between risk factor and disease event may be under-estimated

  • Combination of confounding and effect modification leads to non-linear attenuation

    • Association may appear to be threshold or J-curve


Linear attenuation confounding only

Linear Attenuation(confounding only)

  • Risk level: P = primary risk factor

    R = residual risk level

  • Incidence rate:

    logl(t;P,R) = logl0(t) + aP + bR

  • Confounding: R = c + dP(d<0)

  • Apparent relationship:

    logl(t;S) = logl0*(t) + (a+bd)P

  • Attenuation: a > a+bd


Hypothetical effect

Non

cholesterol

risk level

Hypothetical Effect


Non linear attenuation confounding and effect modification

Non – linear attenuation(confounding and effect modification)

  • Risk level: P = primary risk factor

    R = residual risk level

  • Incidence rate:

    logl(t;S,NS) = logl0(t) + (a+a0R)P + bR

  • Confounding: R = c + dP (d<0)

  • Apparent relationship:

    logl(t;S) = logl0*(t) + (a+a0c+bd)P + a0dP2

  • Attenuation: apparent quadratic relationship


Hypothetical effect1

Non

cholesterol

risk level

Hypothetical Effect


Theoretical calculations under the assumption that lower is better

Theoretical Calculations(under the assumption that lower-is-better)


Apparent relationships

Apparent Relationships

  • Bias can lead to apparent thresholds and J-curves even when the underlying model is linear


Adjustment for measurement error regression dilution

Adjustment for measurement error (regression dilution)

  • Measurement error accounts for some but not all of the attenuation


Conclusions

Conclusions

  • Analyses showing an apparent threshold relationship may not be inconsistent with a linear “lower is better” relationship

  • Aggressive treatment strategies may be warranted despite an apparent threshold or J-curve in the risk factor

  • Analyses adjusting for residual risk level are crucial and may ameliorate the bias


Randomised studies2

Randomised Studies

  • Interventionstrategiesarebestbasedonrandomisedtrialscomparing(lessaggressive)threshold-basedinterventionwith(moreaggressive)non-threshold-basedintervention

  • Example:Despiteearliersuggestionsofacholesterolthreshold,largescaletrialshavenowconfirmedaggressivetreatmentofhighriskpatientsevenatlowercholesterollevels


Final word

Final Word

  • Even when we are confident that there is no bias in the risk factor model, assessment of risk factor intervention strategies can be dangerous based solely on risk factor models derived from prospective cohort studies

  • Degree of improvement in the risk factor may not be a complete “surrogate” for the effect of the intervention

  • Randomised studies capture the complete effects of the intervention and are therefore preferable for assessing risk factor interventions strategies


Randomised studies3

Randomised Studies

  • Interventionstrategiesarebestbasedonrandomisedtrialscomparing(lessaggressive)threshold-basedinterventionwith(moreaggressive)non-threshold-basedintervention

  • Example:Despiteearliersuggestionsofacholesterolthreshold,largescaletrialshavenowconfirmedaggressivetreatmentofhighriskpatientsevenatlowercholesterollevels


Example simulation results1

Example – Simulation Results

Assumptions for simulated population:

Incidence of coronary event is related to 8 risk factors (incl. cholesterol) according to a model

No relationship between cholesterol and no. of non-cholesterol risk factors in the full population

Coronary events simulated according to the risk factor model

Primary and secondary prevention sub-populations identified


  • Login